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Introduction: Changes in personality have been described in Parkinson's disease (PD), with suggestion
that those with established disease tend to be risk averse with a disinclination for addictive behaviour.
However, little is known about the earliest and prodromal stages. Personality and its relationship with
addictive behaviours can help answer important questions about the mechanisms underlying PD and
addiction.
Methods: 941 population-ascertained PD subjects within 3.5 years of diagnosis, 128 patients with rapid
eye movement sleep behaviour disorder (RBD) and 292 control subjects were fully characterised for
motor symptoms, non-motor symptoms and across the following 5 personality domains: 1) neuroticism
2) extraversion 3) conscientiousness 4) agreeableness 5) openness using the Big Five Inventory.
Results: Patients with early PD were more neurotic (p < 0.001), less extraverted (p < 0.001) and less open
than controls (p < 0.001). RBD subjects showed the same pattern of being more neurotic (p < 0.001), less
extraverted (p ¼ 0.03) and less open (p < 0.001). PD patients had smoked less (p ¼ 0.02) and drunk less
alcohol (p ¼ 0.03) than controls, but caffeine beverage consumption was similar. Being more extraverted
(p < 0.001), more open (p < 0.001), and less neurotic (p < 0.001) predicted higher alcohol use, while
being more extravert (p ¼ 0.007) and less agreeable (p < 0.001) was associated with smoking more.
Conclusions: A similar pattern of personality changes is seen in PD and RBD compared to a control
population. Personality characteristics were associated with addictive behaviours, suggestive of a com-
mon link, but the lower rates of addictive behaviours before and after the onset of motor symptoms in PD
persisted after accounting for personality.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
While still controversial, a pre-morbid personality has been
associated with Parkinson's disease (PD) since 1913 [1]. Assessment
of personality varies depending on the model used, however some
report that patients with established PD have a proﬁle of less
novelty seeking andmore harm avoidance [2]. Other features relatey, Level 3, West Wing, John
.
. Hu).
r Ltd. This is an open access articleto over controlled personality traits with introversion, mental ri-
gidity, tenseness, social alertness and cautiousness [3]. It has been
argued that reduced striatal dopaminergic signalling may cause
these personality traits. There is also evidence that PD patients
engage in less addictive behaviours than the general population,
such as smoking, alcohol and caffeine use, whichmay ormay not be
secondary to these personality differences [4,5]. Conversely, a sig-
niﬁcant proportion of patients can develop impulsive-compulsive
behaviours (ICB) when treated with dopamine agonists [6]. In the
general population, novelty seeking behaviour is associated with
impulsive/addictive syndromes, linked to an exaggerated dopami-
nergic response to novel or rewarding stimuli [7]. Theseunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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both personality traits and reward or novelty based behaviour.
There have been few well-designed prospective studies inves-
tigating personality in this earliest stage of the disease process [2]
or in the prodromal phase. The latter can be investigated with a
cohort of patients with REM sleep behaviour disorder (RBD)
because of their high risk of future conversion to PD and evidence,
even at this stage, of a functional change in dopamine circuitry [8].
We have examined the following questions using the Oxford Dis-
covery study comprising a large well-phenotyped PD cohort, RBD
patients and population controls. (1) Does the personality of PD
patients differ from controls in the early and pre-motor stages? (2)
Can one explain differing patterns in addiction prone behaviours,
such as smoking, caffeine and alcohol consumption in PD, by
different personality proﬁles?
2. Materials and methods
2.1. Participants
Full details of the protocol have been described elsewhere [9]. In
brief, PD patients diagnosed within 3.5 years were recruited be-
tween September 2010 and February 2014. Cases were eligible for
inclusion if they met the UK PD Brain Bank criteria for diagnosis
[10] irrespective of their age at PD onset, family history or cognitive
status, while atypical cases were excluded. Cases diagnosed with
dementia within one year of diagnosis were excluded as cases of
Lewy body dementia.
The control population were clinically assessed to ensure they
did not have PD or a ﬁrst-degree relative with PD. The ‘RBD’ group
comprised of participants with a diagnosis made by clinical
assessment and polysomnography according to standard Interna-
tional Classiﬁcation of Sleep Disorders-II criteria [11].
2.2. Clinical assessment
Personality was assessed using the Big Five Inventory (BFI-44).
This is a self-rated questionnaire that uses a 5-point scale to rate 44
short phrases of character to evaluate the ﬁve factor model of
personality: extraversion; neuroticism; agreeableness; openness;
and conscientiousness (see supplemental tables 1 and 2) [12].
The addictive behaviours assessed were smoking, alcohol and
caffeine use, each scored using the Mini Environmental Risk
Questionnaire for PD. Current and past use for each was assessed,
with consumption before diagnosis used for pre-morbid assess-
ment in the PD group. A broad range of non-motor symptoms
(NMS) were assessed, details of the tests and thresholds for positive
symptoms are shown in supplemental table 3.
Motor function was assessed using MDS-UPDRS III and Hoehn
and Yahr staging. PD patients were classiﬁed into three motor
phenotypes (postural instability and gait difﬁculty (PIGD), tremor
dominant (TD) and indeterminate) based on their MDS-UPDRS
motor score [13].
We also collected data on socioeconomic status (type of ac-
commodation and vehicle ownership) and education level (using
years in formal education) to adjust for the potential confounding
effect of socio-economic position on addiction prone behaviours
that are socially patterned.
2.3. Statistical analysis
Continuous demographic variables were compared using
ANOVA or Kruskall-Wallis tests (if distribution was not Gaussian).
The chi-squared test was used for categorical data. Missing data
was excluded from the analysis.We initially tested whether there were differences in person-
ality (outcome) by our three exposure groups (PD, RBD, controls).
Each personality domainwas categorised into quintiles and ordinal
logistic regression was used to calculate the odds ratio (OR) for a
unit change in the outcome as the assumptions required for linear
regression were not valid. The Wald test of parallel lines assump-
tions was used to test the model was appropriate. We used multi-
variable models in our comparison between groups, incrementally
adjusting for age, gender, affective disorders (anxiety and depres-
sion) and cognition. For comparison of PD subtypes, our regression
models also included disease duration, motor severity and levo-
dopa equivalent daily dose (LEDD).
We then tested whether disease status predicted our three
addiction prone behaviours: smoking, alcohol and caffeine
beverage consumption, which we had categorised into ordinal
variables (see supplemental table 3). Our initial models adjusted for
age, gender, socioeconomic status and educational level. We then
adjusted for each of the 5 personality factors (the log of the total
individual score was used due to non-normality) to see if this
attenuated the associations. Finally to look at how personality
predicted addiction prone behaviours, we pooled together all
subjects (regardless of disease status) and adjusted for age, gender,
socio-economic position and educational level.
We used a threshold of 0.05 as a level of statistical signiﬁcance,
but due to multiple testing, p-values between 0.05 and 0.001
should be interpreted with caution as they may reﬂect a type I
error.
3. Results
Baseline data from 1361 participants (941 PD, 128 RBD and 292
controls) were included (Fig. 1). Basic demographics are shown in
Table 1. Missing data in each variable was less than 3% except for
the BDI (5.2%) and the QUIP-S (4.7%) leaving us with 1112 (81.7%)
complete cases.
3.1. Comparison of personality in the early PD, RBD and control
groups
The PD groupwas older than the control (p < 0.001) and the RBD
groups (p ¼ 0.01), which had similar age. There were substantially
fewer women in the RBD group (13.3%) compared to both controls
(51.0%) and PD group (35.2%) (both p values < 0.001) and the PD
group also had fewer women than the controls. The control group
were wealthier and more educated than both the PD and RBD
groups (all p-values< 0.05). The PD group ownedmore of their own
accommodation (p ¼ 0.007) and had more bedrooms than the RBD
group (p ¼ 0.008).
Neuroticism and extraversion showed the biggest absolute dif-
ferences between the control group and the others (see
supplemental Fig. 1). Adjusting for age and gender, PD cases were
more neurotic (OR 2.03, 95% CI 1.59, 2.58, p < 0.001), less extra-
verted (OR 0.53, 95% CI 0.42, 0.68, p < 0.001) and less open than the
control group (OR 0.55, 95% CI 0.44, 0.70, p < 0.001) (see Table 2).
The same pattern was seen when comparing the RBD group with
controls, who were more neurotic (OR 3.07, 95% CI, 2.09, 4.52,
p < 0.001), less extraverted (OR 0.65, 95% CI 0.44, 0.95, p ¼ 0.03)
and less open (OR 0.49, 95% CI 0.34, 0.72, p < 0.001). The addition of
mood (depression and anxiety) and cognition as additional co-
variates in the regression model had little effect on most of the
results, except for neuroticism, which showed moderate attenua-
tion with the addition of mood (OR for PD cases versus controls
went from 2.03 to 1.49). Again the same pattern was seen in the
RBD group following this adjustment, so they remained more
neurotic and less open, but there was moderate attenuation for
Fig. 1. Flow chart of participant inclusion and exclusion.
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versus controls went from 0.65 to 0.85).
PD patients with the PIGD phenotypewere less extraverted than
the tremor dominant phenotype (OR 0.66, 95% CI 0.51, 0.87,
p ¼ 0.003) and more neurotic (OR 1.47, 95% CI 1.21,1.92, p ¼ 0.005)
but were otherwise similar (see supplementary Table 4). PD pa-
tients with RBD were more neurotic (OR 2.02, 95% CI 1.59, 2.58,
p < 0.001), which was consistent with the other patterns, but were
also less agreeable (OR 0.71, 95% CI 0.56, 0.90), p ¼ 0.005) and less
conscientious (OR 0.69, 95% CI 0.54,0.88, p ¼ 0.002). Treated PD
patients (not on dopamine replacement therapy) were less open
than untreated PD patients (OR 0.64, 95% CI 0.44, 0.92, p¼ 0.02) but
were otherwise similar (see supplementary Table 5). Differences
between untreated PD patients and controls were attenuatedcompared to the whole PD group comparison, particularly the
differences in openness were no longer evident (OR 0.81, 95% CI
0.55, 1.20, p ¼ 0.30).
We undertook a number of sensitivity analyses by excluding
younger (aged <50 years) or demented (MOCA <24) subjects in the
comparison of personality between the patient groups, which had
little effect on the results.3.2. Smoking, alcohol and caffeine consumption
PD patients were less likely to have smoked regularly (at least 1
cigarette a day for 6 months) than controls (OR 0.72, 95% CI
0.54,0.96, p ¼ 0.03). However, the difference was greater following
diagnosis, with a greater proportion of PD patients having given up
Table 1
Demographics of each subject group.
PD
(n ¼ 941)
RBD
(n ¼ 128)
Controls
(n ¼ 292)
Age (mean, range (SD)) 67.2, 32-90
(9.6)
65.0, 29-81
(8.9)
65.1, 28e88 (10.0)
Gender (female n (%)) 332 (35.2) 17 (13.3) 148 (51.0)
Ethnicity (non-white n (%)) 20 (2.1) 3 (2.3) 6 (2.1)
First-degree relatives with PD (n (%)) 147 (15.7) 8 (6.3) 0
Age of PD motor symptom onset (mean, range (SD)) 64.3, 20-87
(9.8)
n/a n/a
Disease duration from PD diagnosis in years (mean, range (SD)) 1.3, 0.01e3.5
(0.9)
n/a n/a
MDS-UPDRS III (mean (SD)) 26.4 (10.8) 4.3 (4.3) 1.7 (2.7)
Hoehn and Yahr Stage (n (%))
1 215 (23.0) n/a n/a
2 658 (70.2) n/a n/a
3 64 (6.8) n/a n/a
Untreated PD (n (%)) 120 (12.8) n/a n/a
Levodopa equivalent daily dosage (treated patients only) (mean (SD)) 323 (196) n/a n/a
Treated participants were on the following medications (n (%))a:
Levodopa 519 (63.3) n/a n/a
Dopamine agonist 280 (34.2)
MAOB-I 229 (27.9)
Cognition (Montreal Cognitive Assessment) (mean, median (interquartile range)) 25.0, 25 (23e27) 25.3, 26 (24e27) 26.7 (25e29)
Depression (Beck's Depression Inventory-II) (mean, median (interquartile range)) 8.8, 8 (4e12) 9.8, 6 (2e15) 4.8, 4 (1e7)
Depression (Beck's Depression Inventory-II) (positive screen (n (%)) 157 (17.8) 34 (27.6) 18 (6.4)
Anxiety (Leeds Anxiety and Depression Scale) (mean, median (interquartile range)) 3.4, 3 (1e5) 4.1, 3.5 (1e6) 2.1, 2 (0e3)
Anxiety (Leeds Anxiety and Depression Scale) positive screen (n (%)) 159 (17.2) 27 (21.4) 17 (5.9)
Impulse Control Behaviours (QUIP-S)b positive screen (n (%)) 195 (22.0) 40 (32.0) 61 (21.5)
RBDc (RBD Sleep Questionnaire) (mean, median (interquartile range)) 4.8, 4 (2e7) 10.1, 10 (9e12) 2.7, 2 (1e4)
Daytime somnolence (Epworth Sleepiness Scale) (mean, median (interquartile range)) 7.6, 7 (4e10) 7.3, 6.5 (4e10) 5.7, 5 (3e8)
Ever smoked (n (%)) 382 (40.8) 82 (64.1) 127 (43.5)
Current smokers (n (%)) 23 (2.5) 10 (7.8) 13 (4.5)
Smoking history in pack years (smokers only) (mean, median (interquartile range) 15.8, 10 (3.75e21) 27.0, 15 (6e40) 14.5, 10 (3.5e20)
Prior alcohol use in units per week (mean, median (interquartile range) 10.5, 6 (1e14) 16.2, 9.5 (2e24) 11.4, 8 (2e18)
Current alcohol use in units per week (mean, median (interquartile range) 7.9, 4 (0e10) 8.9, 4.5 (0e12) 9.5, 6 (1e14)
Prior caffeine use in total beverages per day (mean, median (interquartile range) 4.8, 5 (3e6) 5.3, 5 (3e6) 4.7, 5 (3e6)
Current caffeine use in total beverages per day (mean, median (interquartile range) 4.1, 4 (2e6) 3.9, 4 (3e5) 4.1, 4 (3e6)
Number of vascular risk factorsd(n (%))
0 434 (46.3) 55 (43.3) 157 (53.8)
1 260 (27.7) 25 (19.7) 70 (24.0)
>2 244 (26.0) 47 (37.0) 65 (22.3)
Big Five Inventory:
Extraversion (mean (SD)) 24.3 (6.7) 25.0 (6.5) 27.1 (6.7)
Neuroticism (mean (SD)) 22.2 (6.6) 24.1 (7.3) 19.8 (6.7)
Agreeableness (mean (SD)) 36.8 (5.1) 34.8 (5.6) 36.8 (4.9)
Openness (mean (SD)) 34.8 (7.1) 34.5 (6.6) 37.2 (6.9)
Conscientiousness (mean (SD)) 35.8 (5.8) 35.0 (6.3) 36.4 (5.8)
Social Background:
Accommodation owned, (n, %) 859 (91.7) 108 (84.4) 277 (95.2)
More than 3 Bedrooms in accommodation, (n, %) 407 (44.5) 40 (32.0) 151 (52.4)
More than 1 vehicle owned, (n, %) 458 (50.3) 53 (43.4) 158 (55.1)
Number of years in formal education (mean, median, interquartile range) 14.0, 14 (11e16) 13.8, 13 (11e16) 15.1, 16 (12e17)
a Percentages relate to the number on each drug, some patients are on more than one class of drug.
b Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease.
c Rapid Eye Movement Sleep Behaviour Disorder.
d Includes angina, heart failure, stroke or TIA, heart attack, diabetes, hypercholesterolaemia and hypertension.
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consumption (pack years smoked) (see Table 3), this showed the
same pattern of PD patients smoking less than controls (OR 0.71,
95% CI 0.54, 0.93, p ¼ 0.02). However, there was modest evidence
that RBD patients possibly smoked more than controls (OR 1.55,
95% CI 1.01, 2.37, p ¼ 0.05). Adjusting for personality in the model
made little difference to the results except for alcohol consumption,
which showed modest attenuation for PD versus controls (OR
0.70e0.79). PD patients with RBD symptoms may have had a
modestly higher rate of smoking than those without (OR 1.33, 95%
CI 0.99, 1.79, p ¼ 0.06), but this difference was not statistically
signiﬁcant.
Personality traits were associated with addictive behaviours
(see supplementary table 6). Being more extravert (OR 1.74, 95% CI1.16, 2.60, p ¼ 0.007) and less agreeable (OR 0.23, 95% CI 0.13, 0.56,
p < 0.001) was associated with higher smoking consumption.
Higher scores in extraversion (OR 2.14, 95% CI 1.44, 3.17), p < 0.001)
and openness (OR 2.98, 95% CI 1.75, 5.06), p < 0.001), as well as
lower neuroticism scores (OR 0.55, 95% CI 0.40, 0.76), p < 0.001),
predicted higher alcohol consumption. These associations
remained despite adjusting for mood and cognition, although the
affect of neuroticism was less pronounced.
4. Discussion
4.1. Personality in PD and prodromal PD
Our ﬁndings support and build on some of the previous studies
Table 2
Comparison of personality type between subject groups.
Co-variates included in
model
PD vs Controls (OR (95% CI); p value) RBD vs Controls (OR (95% CI); p value)
Age and gender Age, gender and
mood
Age, gender, mood and
cognition
Age and gender Age, gender and
mood
Age, gender, mood and
cognition
Extraversion 0.53 (0.42e0.68),
p < 0.001
0.60 (0.47e0.77),
p < 0.001
0.61 (0.47e0.78),
p < 0.001
0.65 (0.44e0.95),
p ¼ 0.03
0.85 (0.57e1.26),
p ¼ 0.42
0.87 (0.58e1.30), p¼ 0.50
Neuroticism 2.03 (1.59e2.58),
p < 0.001
1.49 (1.16e1.92),
p ¼ 0.002
1.49 (1.16e1.92),
p ¼ 0.002
3.07 (2.09e4.52),
p < 0.001
1.91 (1.27e2.86),
p ¼ 0.002
1.93 (1.29e2.90),
p ¼ 0.001
Agreeableness 1.12 (0.89e1.42),
p ¼ 0.33
1.25 (0.98e1.60),
p ¼ 0.07
1.23 (0.97e1.59), p¼ 0.09 0.74 (0.51e1.08),
p ¼ 0.12
0.91 (0.61e1.35),
p ¼ 0.64
0.93 (0.62e1.38), p¼ 0.70
Openness 0.55 (0.44e0.70),
p < 0.001
0.54 (0.43e0.70),
P < 0.001
0.57 (0.44e0.73),
p < 0.001
0.49 (0.34e0.72),
p < 0.001
0.56 (0.38e0.83),
p ¼ 0.004
0.57 (0.38e0.84),
p ¼ 0.005
Conscientiousness 0.86 (0.68e1.08),
p ¼ 0.20
0.99 (0.77e1.27),
p ¼ 0.93
1.03 (0.80e1.32), p¼ 0.80 0.77 (0.52e1.12),
p ¼ 0.18
0.99 (0.67e1.47),
p ¼ 0.96
0.99 (0.67e1.48), p¼ 0.97
The total score for each personality trait was divided into quintiles with ordinal logistic regression then used to calculate odds ratios. The co-variates for each regressionmodel
is listed.
Table 3
Comparison of smoking, alcohol and caffeine between groups.
Pre-morbid/Past Use Current Use
Smoking Alcohol Caffeine Alcohol Caffeine
PD vs Controls (OR (95% CI); p value) 0.71 (0.54e0.93),
p ¼ 0.02
0.70 (0.53e0.91),
p ¼ 0.009
1.00 (0.78e1.29),
p ¼ 0.98
0.59 (0.45e0.77),
p < 0.001
0.92 (0.71e1.18),
p ¼ 0.50
PD vs Controls (OR (95% CI); p value) [adjusting for
personality]
0.73 (0.55e0.97),
p ¼ 0.03
0.79 (0.60e1.05),
p ¼ 0.11
0.93 (0.71e1.21),
p ¼ 0.58
0.66 (0.50e0.87),
p ¼ 0.004
0.85 (0.65e1.11),
p ¼ 0.24
RBD vs Controls (OR (95% CI); p value) 1.55 (1.01e2.37),
p ¼ 0.05
0.94 (0.60e1.47),
p ¼ 0.78
1.16 (0.78e1.75),
p ¼ 0.48
0.60 (0.39e0.93),
p ¼ 0.02
0.78 (0.52e1.18),
p ¼ 0.24
RBD vs Controls (OR (95% CI); p value) [adjusting for
personality]
1.62 (1.04e2.53),
p ¼ 0.03
0.97 (0.61e1.54),
p ¼ 0.89
1.15 (0.75e1.77),
p ¼ 0.52
0.64 (0.40e1.01),
p ¼ 0.06
0.78 (0.51e1.18),
p ¼ 0.24
The number of pack years smoked, weekly alcohol intake (current and past) and daily caffeine intake (current and past) were used for analysis. There were not enough current
smokers to model current smoking behaviours between groups.
Ordered logistic regression was used to calculate odds ratios, adjusted for age, gender and socio-economic position to compare the patient groups using pre-morbid or current
consumption levels. Each of the ﬁve factors were included in the model as co-variates in addition to compare the effects of personality on addictive behaviours between the
groups.
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more introverted and neurotic. The presence of these personality
differences in RBD and in the early stages of PD infers that these
changes start before the onset of motor symptoms. Most previous
studies have used personality assessments based on Cloninger's
psychobiological model [14]. They demonstrated that PD patients
had less novelty seeking and more harm avoidance characteristics
than control populations [2,15]. Using the ﬁve factor model, PD
patients were shown to be more neurotic and less extraverted than
controls if the patient was depressed [16]. Two other studies have
shown less extraversion and conscientiousness in the PD group [17]
or no differences in personality [18]. However these studies were
small and potentially underpowered to detect differences. A major
strength of this study is that the personality differences largely
persisted despite adjusting for mood and cognition, which can
affect the assessment of personality traits [15].
Sieurin et al. recently published the results of a prospective twin
study which found neuroticism and introversion to be more com-
mon in subjects who converted to PD [19], in support of a pro-
dromal PD personality. Postuma et al. found that RBD patients
scored higher on harm avoidance than controls using the Tridi-
mensional Personality Questionnaire [20]. Importantly these per-
sonality differences did not predict conversion to PD, implying that
they remained relatively stable through the prodromal stage to
conversion [21]. However Sasai et al. were unable to replicate these
ﬁndings in an independent cohort using a ﬁve-factor model (NEO-
PIR), although the study may have been too small to detect a dif-
ference [22]. This study adds considerable evidence to the conceptof a prodromal personality proﬁle, with the differences detected
reﬂecting the same pattern of differences as the early PD group.
Proposed subtypes of PD may have different disease mecha-
nisms, with the prevalence and severity of NMS being key dis-
tinguishing features. The same pattern of differences seen between
PD and controls was again reﬂected in the differences between the
PIGD and TD groups, consistent with a more severe NMS disease
burden and more aggressive disease process. That PD patients with
RBD were more neurotic than those without may also be a reﬂec-
tion of this, consistent with previous evidence that these patients
have different phenotypic features [23,24]. It remains unclear
whether these differences are a direct result of the underlying
pathophysiology or a consequence of disturbed sleep.
The attenuation of the differences, particularly in openness,
between the untreated PD participants and controls, may be driven
by these patients having a less aggressive disease process. As the
study design recruited subjects with early Parkinson's rather than
at the time of diagnosis, this result could just reﬂect a milder
subtype of PD. The phenotypic differences between subtypes is
more complex than primarily driven by dopamine dysfunction [25].
Thus while we have provided evidence of personality differences
between subtypes, the similarities between treated and untreated
PD cases may reﬂect that these affects are due to changes in
alternative pathways.4.2. Addictive behaviours in PD
There is a body of epidemiological evidence that suggests that
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postulated that this inverse association with addictive behaviours
may be a reﬂection of the personality traits associated with PD,
driven by disruption of dopaminergic signalling. Analyses, when
adjusted for differences in personality as a potential confounder,
still found a robust difference in smoking rates between the PD
group and controls. This suggests personality and certain reward-
based activities are independent factors, consistent with the
Swedish twin registry study (n ¼ 197) [19] that also found a direct
effect of neuroticism increasing the risk of PD using mediation
analysis (i.e. conditioning out any indirect effect through a smoking
mediator pathway).
PD patients were more likely to have given up smoking than
controls, potentially a result of disease progression affecting reward
sensitivity in this group. A similar ﬁnding was reported in early,
untreated PD patients although we are unable to comment on the
reasons for individuals quitting smoking [27].
Somewhat surprisingly, the RBD patients were more likely to
have smoked than either the control or PD population, replicating
the results of a previous large study of RBD patients [28]. The
reasons for this are not clear and the trend of PD patients with RBD
to smoke more than those without RBD replicates the ﬁnding of a
previous study [29]. This may provide further support for PD het-
erogeneity with possibly different pathophysiological mechanisms
or reﬂect behavioural changes due to the symptoms of the condi-
tion. A large population study using a screening questionnaire to
diagnose probable RBD did not ﬁnd this association with smoking,
but this may be due to misclassiﬁcation due to the assessment
method [30].
Alcohol consumptionwas similar in the RBD group and controls,
but less in the PD group. Personality accounted for more of the
differences between the cases and controls than in the smoking
comparison, but the overall affect was still small. Caffeine beverage
consumption was similar across groups, possibly because the ab-
solute caffeine value of different drinks was not assessed.
Extraversion was the only trait that predicted both higher
smoking and alcohol consumption. Being more extravert is thought
to represent an underlying sensitivity to reward, thus its associa-
tion with addictive behaviour is intuitive. In addition to extraver-
sion, openness was positively associated with higher alcohol use
and neuroticism was inversely associated. This pattern of person-
ality traits predicting more alcohol use is the inverse of the per-
sonality differences between cases and controls which suggests a
common link between the mechanisms underlying personality
differences and addictive behaviour in PD. Differences in how in-
dividual personality traits (particularly extraversion) are associated
with smoking and alcohol may be linked by reward sensitivity. This
is potentially driven by dysfunction of dopaminergic signalling in
PD, which mediates reward sensitivity. Personality changes do not
seem to fully explain these differences, potentially a result of these
changes evolving due to more pathways than just dopamine
dysfunction.
Major strengths of our study include: (i) The sizeable numbers
of both RBD patients and a control population for direct comparison
(ii) This is one of the largest studies published examining the per-
sonality type in the PD population (iii) The inclusion of patients
with incident cognitive impairment is a strength, as their exclusion
may bias the ﬁndings to milder PD subtypes. There are several
study limitations that need to be considered. (i) The ﬁve-factor
model of personality is widely accepted, however the ‘short form’
of assessment was used due to practical constraints. (ii) Whilst the
attempt was made to adjust for demographic differences between
groups, there may still be residual confounding differences. The
Swedish twin study found much weaker associations between
personality and PD when they did a within-twin pair analysis,suggesting familial confounding factors may partially generate the
observed association in unrelated individuals [19]. (iii) Our obser-
vations may be susceptible to recall bias, although the results are
consistent with the few prospective studies that have collected data
on personality and addiction prone behaviours well before disease
onset. (iv) It is uncertain which RBD patients will convert to PD and
when. However, this would likely reduce rather than exaggerate
any potential ‘prodromal’ characteristics of PD.
5. Conclusion
This study supports the concept of personality differences be-
tween PD and control subjects, even in the earliest stages of the
motor phase of the disease. The similar pattern found in RBD pa-
tients (a surrogate for prodromal PD) is strongly suggestive of these
personality changes occurring before motor symptom onset. Ex-
traversion, which has been linked with reward sensitivity, is posi-
tively associatedwith smoking and alcohol consumption. The lower
rates of addictive behaviours before and after the onset of motor
symptoms in PD are not explained by the personality changes
alone, at least as measured by the ﬁve factor model. However, the
same personality characteristics that are affected in PD are associ-
ated with addictive behaviours, which is strongly suggestive of a
common link.
Ethics approval
Ethical approval for this study was granted by the Berkshire
Ethics Committee, South Central, National Research Ethics Service
(UK): reference number 10/H0505/71. All participating subjects
provided informed written consent.
Financial disclosure/conﬂict of interest
The authors have no conﬂicts of interest to declare. The OPDC
Discovery cohort is funded by the Monument Trust Discovery
Award from Parkinson's UK (grant number J-1403) and supported
by the National Institute for Health Research (NIHR) Oxford
Biomedical Research Centre based at Oxford University Hospitals
NHS Trust and University of Oxford, and the Dementias and
Neurodegenerative Diseases Research Network (DeNDRoN).
Full ﬁnancial disclosures of all authors for the past year
FB e Employed by the Oxford Parkinson's Disease Centre, UK.
ML e Employed by the School of Social and Community Medi-
cine, UK.
MR e Funded by the British Research Council, UK.
CR - Employed by the Oxford Parkinson's Disease Centre, UK.
JK - Employed by the Oxford Parkinson's Disease Centre, UK.
KN e Employed by Northampton General Hospital, UK.
DO e Employed by Oxford University Hospitals Trust, UK.
YBS - Advisory Boards: member of the Multiple Sclerosis -risk
sharing scheme scientiﬁc advisory board. Employed by the Uni-
versity of Bristol. Royalties from books published by Oxford Uni-
versity Press and Wiley. Grants received from Parkinson's UK,
Cancer Research UK, National Institute of Health Research, British
Heart Foundation and Medical Research Council.
MH e Funded by OPDC Monument Discovery award, the Oxford
Biomedical Research Centre and National Institute of Health
Research Clinical Research Network.
Author roles
1. Research Project: A. Conception, B. Organization, C. Execution;
F. Baig et al. / Parkinsonism and Related Disorders 37 (2017) 72e78782. Statistical Analysis: A. Design, B. Execution, C. Review and
Critique; 3. Manuscript Preparation: A. Writing the First Draft, B.
Review and Critique.
FB: 1A, 1C, 2A, 2B, 3A.
ML: 2A, 2B, 2C, 3B.
MR: 1C, 3B.
CR: 1C, 3B.
JK: 1C, 3B.
KN: 1C, 3B.
DO: 1A, 2C, 3B.
YBS: 1A, 1B, 2B, 2C, 3B.
MH: 1A, 1B, 1C, 2C, 3B.
Competing interests
None.
Acknowledgements
The authors would like to thank everyone who participated in
this study, without whom none of this would have been possible.
We would also like to thank Dr Paul Tomlinson, Dr Konrad
Szewczyk-Krolikowski, and all of the administrative and nursing
support from the OPDC and Dendron team for their contributions.
This study was funded by the Monument Trust Discovery Award
from Parkinson's UK and supported by the National Institute for
Health Research (NIHR) Oxford Biomedical Research Centre based
at Oxford University Hospitals NHS Trust and University of Oxford,
and the NIHR Clinical Research Network: Thames Valley and South
Midlands.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.parkreldis.2017.01.017.
References
[1] C.J. Todes, A.J. Lees, The pre-morbid personality of patients with Parkinson's
disease, J. Neurol. Neurosurg. Psychiatr. 48 (2) (1985) 97e100.
[2] M. Poletti, U. Bonuccelli, Personality traits in patients with Parkinson's dis-
ease: assessment and clinical implications, J. Neurol. 259 (6) (2012)
1029e1038.
[3] A.H. Evans, A.D. Lawrence, J. Potts, L. MacGregor, R. Katzenschlager, K. Shaw,
J. Zijlmans, A.J. Lees, Relationship between impulsive sensation seeking traits,
smoking, alcohol and caffeine intake, and Parkinson's disease, J. Neurol.
Neurosurg. Psychiatr. 77 (3) (2006) 317e321.
[4] M.A. Hernan, B. Takkouche, F. Caamano-Isorna, J.J. Gestal-Otero, A meta-
analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's
disease, Ann. Neurol. 52 (3) (2002) 276e284.
[5] D. Zhang, H. Jiang, J. Xie, Alcohol intake and risk of Parkinson's disease: a
MetaAnalysis of observational studies, Mov. Disord. 29 (6) (2014) 819e822.
[6] M.B. Callesen, J. Scheel-Krueger, M.L. Kringelbach, A. Moller, A systematic
review of impulse control disorders in Parkinson's disease, J. Park. Dis. 3 (2)
(2013) 105e138.
[7] A. Dagher, T.W. Robbins, Personality, addiction, dopamine: insights from
Parkinson's disease, Neuron 61 (4) (2009) 502e510.
[8] M. Rolinski, L. Griffanti, K. Szewczyk-Krolikowski, R.A.L. Menke, G.K. Wilcock,
N. Filippini, G. Zamboni, M.T.M. Hu, C.E. Mackay, Aberrant functional con-
nectivity within the basal ganglia of patients with Parkinson's disease, Neu-
roImage Clin. 8 (2015) 126e132.
[9] K. Szewczyk-Krolikowski, P. Tomlinson, K. Nithi, R. Wade-Martins, K. Talbot,
Y. Ben-Shlomo, M.T.M. Hu, The inﬂuence of age and gender on motor and non-
motor features of early Parkinson's disease: initial ﬁndings from the Oxford
Parkinson Disease Center (OPDC) discovery cohort, Park. Relat. Disord. 20 (1)(2014) 99e105.
[10] A.J. Hughes, S.E. Daniel, L. Kilford, A.J. Lees, Accuracy of clinical-diagnosis of
idiopathic parkinsons-disease - a clinicopathological study of 100 cases,
J. Neurol. Neurosurg. Psychiatr. 55 (3) (1992) 181e184.
[11] O. Lapierre, J. Montplaisir, Polysomnographic features of REM sleep behavior
disorder: development of a scoring method, Neurology 42 (7) (1992)
1371e1374.
[12] C.J. Soto, O.P. John, Ten facet scales for the Big Five Inventory: convergence
with NEO PI-R facets, self-peer agreement, and discriminant validity, J. Res.
Pers. 43 (1) (2009) 84e90.
[13] G.T. Stebbins, C.G. Goetz, D.J. Burn, J. Jankovic, T.K. Khoo, B.C. Tilley, How to
identify tremor dominant and postural instability/gait difﬁculty groups with
the movement disorder society uniﬁed Parkinson's disease rating scale:
comparison with the uniﬁed Parkinson's disease rating scale, Mov. Disord. 28
(5) (2013) 668e670.
[14] C.R. Cloninger, D.M. Svrakic, T.R. Przybeck, A psychobiological model of
temperament and character, Arch. Gen. Psychiatr. 50 (12) (1993) 975e990.
[15] J. Koerts, L. Tucha, K.L. Leenders, O. Tucha, Neuropsychological and emotional
correlates of personality traits in Parkinson's disease, Behav. Neurol. 27 (4)
(2013) 567e574.
[16] M.F. Damholdt, K. Ostergaard, P. Borghammer, L. Larsen, The parkinsonian
personality and concomitant depression, J. Neuropsych. Clin. Neurosci. 23 (1)
(2011) 48e55.
[17] C. Volpato, M. Signorini, F. Meneghello, C. Semenza, Cognitive and personality
features in parkinson disease: 2 sides of the same coin? Cogn. Behav. Neurol.
22 (4) (2009) 258e263.
[18] G. Glosser, C. Clark, B. Freundlich, L. Klinerkrenzel, P. Flaherty, M. Stern,
A controlled investigation of current and premorbid personality - character-
istics of parkinsons-disease patients, Mov. Disord. 10 (2) (1995) 201e206.
[19] J. Sieurin, P. Gustavsson, C.E. Weibull, A.L. Feldman, G.M. Petzinger, M. Gatz,
N.L. Pedersen, K. Wirdefeldt, Personality traits and the risk for Parkinson
disease: a prospective study, Eur. J. Epidemiol. 31 (2) (2015) 169e175.
[20] R.B. Postuma, J.F. Gagnon, M. Vendette, J.Y. Montplaisir, Markers of neuro-
degeneration in idiopathic rapid eye movement sleep behaviour disorder and
Parkinson's disease, Brain 132 (Pt 12)) (2009) 3298e3307.
[21] R.B. Postuma, J.-F. Gagnon, J.-A. Bertrand, D. Genier Marchand, J.Y. Montplaisir,
Parkinson risk in idiopathic REM sleep behavior disorder: preparing for
neuroprotective trials, Neurology 84 (11) (2015) 1104e1113.
[22] T. Sasai, Y. Inoue, M. Matsuura, Do patients with rapid eye movement sleep
behavior disorder have a disease-speciﬁc personality? Park. Relat. Disord. 18
(5) (2012) 616e618.
[23] M. Rolinski, K. Szewczyk-Krolikowski, P.R. Tomlinson, K. Nithi, K. Talbot,
Y. Ben-Shlomo, M.T. Hu, REM sleep behaviour disorder is associated with
worse quality of life and other non-motor features in early Parkinson's dis-
ease, J. Neurol. Neurosurg. Psychiatr. 85 (5) (2014) 560e566.
[24] S.-M. Fereshtehnejad, S.R. Romenets, J.B. Anang, V. Latreille, J.-F. Gagnon,
R.B. Postuma, New clinical subtypes of Parkinson disease and their longitu-
dinal progression: a prospective cohort comparison with other phenotypes,
JAMA Neurol. 72 (8) (2015) 863e873.
[25] R. Erro, M. Picillo, C. Vitale, R. Palladino, M. Amboni, M. Moccia,
M.T. Pellecchia, P. Barone, Clinical clusters and dopaminergic dysfunction in
de-novo Parkinson disease, Park. Relat. Disord. 28 (2016) 137e140.
[26] A. Nicoletti, P. Pugliese, G. Nicoletti, G. Arabia, G. Annesi, M.D. Mari,
P. Lamberti, L. Grasso, R. Marconi, A. Epifanio, L. Morgante, A. Cozzolino,
P. Barone, G. Torchia, A. Quattrone, M. Zappia, Voluptuary habits and clinical
subtypes of Parkinson's disease: the FRAGAMP case-control study, Mov. Dis-
ord. 25 (14) (2010) 2387e2394.
[27] M. Moccia, R. Erro, M. Picillo, E. Vassallo, C. Vitale, K. Longo, M. Amboni,
G. Santangelo, R. Palladino, A. Nardone, M. Triassi, P. Barone, M.T. Pellecchia,
Quitting smoking: an early non-motor feature of Parkinson's disease? Park.
Relat. Disord. 21 (3) (2015) 216e220.
[28] R.B. Postuma, J.Y. Montplaisir, A. Pelletier, Y. Dauvilliers, W. Oertel, A. Iranzo,
L. Ferini-Strambi, I. Arnulf, B. Hogl, R. Manni, T. Miyamoto, G. Mayer,
K. Stiasny-Kolster, M. Puligheddu, Y. Ju, P. Jennum, K. Sonka, J. Santamaria,
M.L. Fantini, M. Zucconi, S. Leu-Semenescu, B. Frauscher, M. Terzaghi,
M. Miyamoto, M.M. Unger, V. Cochen De Cock, C. Wolfson, Environmental risk
factors for REM sleep behavior disorder: a multicenter case-control study,
Neurology 79 (5) (2012) 428e434.
[29] M.L. Jacobs, Y. Dauvilliers, E.K. St Louis, S.J. McCarter, S.R. Romenets,
A. Pelletier, M. Cherif, J.F. Gagnon, R.B. Postuma, Risk factor proﬁle in Par-
kinson's disease subtype with REM sleep behavior disorder, J. Park. Dis. 6 (1)
(2016) 231e237.
[30] J.C. Wong, J. Li, M. Pavlova, S. Chen, A. Wu, S. Wu, X. Gao, Risk factors for
probable REM sleep behavior disorder: a community-based study, Neurology
86 (14) (2016) 1306e1312.
